Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Shaanxi Institute Of Microbiology has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units, indicating separate examination contexts.
EPSTEIN, TODD MATTHEW is the busiest examiner, with 1 pending matter. Counsel should coordinate the portfolio's biotechnology and pharmaceutical positions while preparing responses for each distinct examiner and art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EPSTEIN, TODD MATTHEW | 1 | 60.7% | +43.2% |
| REGLAS, GEORGIANA C | 1 | 39.5% | +35.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19022218 | BACILLUS MOJAVENSIS H12 AND APPLICATION THEREOF IN FREMENTATION PRODUCTION OF LOW-MOLECULAR-WEIGHT PULLULAN | EPSTEIN, TODD MATTHEW | — |
| 18776658 | LOCTOBACILLUS PLANTARUM 121-5 AND APPLICATION THEREOF IN PREPARING RESVERATROL BY CONVERTING POLYDATIN | REGLAS, GEORGIANA C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19022218 | BACILLUS MOJAVENSIS H12 AND APPLICATION THEREOF IN FREMENTATION PRODUCTION OF LOW-MOLECULAR-WEIGHT PULLULAN | EPSTEIN, TODD MATTHEW | — |
| 18776658 | LOCTOBACILLUS PLANTARUM 121-5 AND APPLICATION THEREOF IN PREPARING RESVERATROL BY CONVERTING POLYDATIN | REGLAS, GEORGIANA C | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19022218 | BACILLUS MOJAVENSIS H12 AND APPLICATION THEREOF IN FREMENTATION PRODUCTION OF LOW-MOLECULAR-WEIGHT PULLULAN | EPSTEIN, TODD MATTHEW | 1652 | §101§112 | Non-Final OA | — | Pending | Jan 15, 2025 |
| 18776658 | LOCTOBACILLUS PLANTARUM 121-5 AND APPLICATION THEREOF IN PREPARING RESVERATROL BY CONVERTING POLYDATIN | REGLAS, GEORGIANA C | 1651 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShaanxi Institute Of Microbiology has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.
Todd Matthew Epstein has the most, with 1 of Shaanxi Institute Of Microbiology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.